These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2144365)

  • 21. [Effects of T-activin in viral myocarditis in animal experiments].
    Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
    Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of thymus gland peptides in chronic cholecystitis].
    Rodoman GV; Belousov IuB; Kostrova MV; Petrov OA
    Sov Med; 1991; (3):73-4. PubMed ID: 1882302
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of vilozen on the immune status of erysipelas patients and the prospects for its use for the immune rehabilitation of convalescents].
    Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN
    Lik Sprava; 1992; (11-12):102-4. PubMed ID: 1292201
    [No Abstract]   [Full Text] [Related]  

  • 24. First experience with immunomodulation in septic shock.
    Josten C; Muhr G; Sistermann R
    Prog Clin Biol Res; 1989; 308():989-94. PubMed ID: 2528747
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 26. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin].
    Sakaeva NA; Balabolkin MI; Tabagari DZ
    Sov Med; 1989; (10):39-41. PubMed ID: 2617340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunotherapy of breast cancer patients].
    Korolev VI; Bendiug GD; Dziubko NiA ; Ponomarev IN; Krivorotov AA
    Vrach Delo; 1987 Jun; (6):90-3. PubMed ID: 3630094
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of thymalin in a patient with immunologic deficiency state after thymectomy].
    Abdulkadyrov KM; Shcherbakova EG; Khavinson VKh; Morozov VG; Gerbut GB
    Klin Med (Mosk); 1983 Jun; 61(6):36-8. PubMed ID: 6604193
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indices of cellular and humoral immunity in patients with disseminated sclerosis being treated with immunomodulators].
    Zapadniuk BV; Kravets AS; Iarosh AA; Shurinok LA
    Vrach Delo; 1988 Aug; (8):84-6. PubMed ID: 3206892
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI; Gergert VIa; Khomenko IS
    Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
    Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
    Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    Iutskovskiĭ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
    Samsygin SA; Dolgina EN; Arion VYa ; Romanova LA; Shchevochkina GI; Ovchinnikova EA
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunological indicators in children with laryngeal papillomatosis and possible ways of immunocorrection].
    Garashchenko TI; Markova TP; Chuvirov DG
    Vestn Otorinolaringol; 1996; (4):15-8. PubMed ID: 8966870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
    Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV
    Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960
    [No Abstract]   [Full Text] [Related]  

  • 37. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of neutrophils in the pathogenesis of psoriasis and the effect of T-activin on them].
    Korotkiĭ NG; Udzhukhu VIu; Vasil'eva LL; Redchenko EB; Bagandov TI
    Vestn Dermatol Venerol; 1987; (7):19-22. PubMed ID: 3673241
    [No Abstract]   [Full Text] [Related]  

  • 39. [Indications for using thymalin in the therapy of children with chronic viral hepatitis B].
    Gol'zand IV; Goriacheva LG; Volkov VO; Khavinson VKh; Morozov VG
    Voen Med Zh; 1986 Mar; (3):27-8. PubMed ID: 3487166
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
    Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.